Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ORAL FORMULATION CONTAINING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID
Document Type and Number:
WIPO Patent Application WO/2022/265442
Kind Code:
A1
Abstract:
The present invention relates to an oral formulation that contains an API selected from 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid or a pharmaceutically acceptable salt thereof, and does not contain pH adjusting agents as excipients. The oral formulation according to the present invention does not contain pH adjusting agents, and thus has the advantages of having increased productivity and convenience of dosage, as well as a high dissolution rate, despite having a high API content.

Inventors:
YOO SEOK CHEOL (KR)
JANG JOOMYUNG (KR)
KIM REE SUN (KR)
SEO JIN A (KR)
Application Number:
PCT/KR2022/008582
Publication Date:
December 22, 2022
Filing Date:
June 17, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
LG CHEMICAL LTD (KR)
International Classes:
A61K9/20; A61K31/4152
Foreign References:
KR20110037883A2011-04-13
KR20120114174A2012-10-16
KR20090128488A2009-12-15
CN106008488A2016-10-12
KR20110132599A2011-12-08
KR101751325B12017-06-27
KR101424013B12014-08-18
Attorney, Agent or Firm:
KIM, Sung Ho (KR)
Download PDF: